172 related articles for article (PubMed ID: 34488412)
1. Pneumonitis, appendicitis, and biliary obstruction during toripalimab treatment in a patient with extensive-stage small-cell lung cancer: a case report.
Qu Y; Wang Z; Feng J; Wang L; Liu H; Liu D; Zhao Y; Yu R; Li W; Sun D; Yu H
Ann Palliat Med; 2021 Aug; 10(8):9267-9275. PubMed ID: 34488412
[TBL] [Abstract][Full Text] [Related]
2. Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: a case report.
Yamakawa H; Oba T; Ohta H; Tsukahara Y; Kida G; Tsumiyama E; Nishizawa T; Kawabe R; Sato S; Akasaka K; Amano M; Kuwano K; Matsushima H
BMC Pulm Med; 2019 Aug; 19(1):156. PubMed ID: 31438923
[TBL] [Abstract][Full Text] [Related]
3. Severe immune-related hyperthermia followed by immune-related pneumonitis with PD-1 inhibitor (sintilimab) in small cell lung cancer: A case report.
Li YH; Zhou Y; Liu YY; Zhang GJ; Xiao L; Li N; Qin HF; Wang JG; Zhang L
Thorac Cancer; 2021 Jun; 12(11):1780-1783. PubMed ID: 33949137
[TBL] [Abstract][Full Text] [Related]
4. Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report.
Liu L; Zhang X; Zhou L; Yang T; Qiao Y; Jiang X
Medicine (Baltimore); 2021 Sep; 100(35):e27138. PubMed ID: 34477165
[TBL] [Abstract][Full Text] [Related]
5. Immune-related adverse events on body CT in patients with small-cell lung cancer treated with immune-checkpoint inhibitors.
Park H; Hatabu H; Ricciuti B; Aijazi SJ; Awad MM; Nishino M
Eur J Radiol; 2020 Nov; 132():109275. PubMed ID: 32949913
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint inhibitor-related chronic pneumonitis: a case report and literature review.
Yuan-Di Wang ; Yuan S; Wen C; Ji Z; Xiang B; Wang B; Zhang Z
Immunotherapy; 2023 Oct; 15(14):1117-1123. PubMed ID: 37431609
[TBL] [Abstract][Full Text] [Related]
7. Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.
Naqash AR; Appah E; Yang LV; Muzaffar M; Marie MA; Mccallen JD; Macherla S; Liles D; Walker PR
J Immunother Cancer; 2019 Jul; 7(1):169. PubMed ID: 31277704
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous development of pneumonitis and autoimmune diabetes secondary to immune checkpoint inhibitor treatment with durvalumab in an advanced small cell lung cancer patient: A case report.
Wen YP; Xiao HW; Yin JH; Guo HR; Shan MJ; Shen LP; Liu LS
Medicine (Baltimore); 2022 Dec; 101(48):e32076. PubMed ID: 36482651
[TBL] [Abstract][Full Text] [Related]
9. Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report.
He Y; An T
J Int Med Res; 2021 Oct; 49(10):3000605211042988. PubMed ID: 34605304
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint inhibitor-related pneumonitis induced by camrelizumab: a case report and review of literature.
Li L; Lou A; Yu J
Ann Palliat Med; 2021 Jul; 10(7):8460-8466. PubMed ID: 34044548
[TBL] [Abstract][Full Text] [Related]
11. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
Beck TN; Kudinov AE; Dulaimi E; Boumber Y
BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
[TBL] [Abstract][Full Text] [Related]
12. Complete response induced by anti-PD-1-based immunotherapy with toripalimab in a patient with locally advanced lung adenocarcinoma who failed rapidly after concurrent chemoradiotherapy: A case report.
Xue W; Zhang T; Wang X; Duan J; Bi N
J Clin Pharm Ther; 2020 Dec; 45(6):1511-1514. PubMed ID: 32893899
[TBL] [Abstract][Full Text] [Related]
13. Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report.
Qiu G; Li S; Li B; Yang Q; Deng H; Yang Y; Xie X; Lin X; Seki N; Miura S; Shukuya T; Zhou C; Liu M
Transl Lung Cancer Res; 2022 Nov; 11(11):2346-2355. PubMed ID: 36519029
[TBL] [Abstract][Full Text] [Related]
14. Intracranial complete response to toripalimab and anlotinib in a patient with recurrent brain metastases of small cell lung cancer after failure of second-line maintenance therapy: a case report.
Huang F; Tang J; Lou J; Wang Q; Ma K; Qiao R; Si J; Kang Y; Chen H; Mei J; Wang H; Liu Y; Miao L
Transl Cancer Res; 2022 Sep; 11(9):3337-3342. PubMed ID: 36237231
[TBL] [Abstract][Full Text] [Related]
15. Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
Chu X; Zhao J; Zhou J; Zhou F; Jiang T; Jiang S; Sun X; You X; Wu F; Ren S; Zhou C; Su C
Lung Cancer; 2020 Dec; 150():76-82. PubMed ID: 33080551
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors.
Pavan A; Calvetti L; Dal Maso A; Attili I; Del Bianco P; Pasello G; Guarneri V; Aprile G; Conte P; Bonanno L
Oncologist; 2019 Aug; 24(8):1128-1136. PubMed ID: 31015312
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Pneumonitis in Patients with Melanoma Treated with Immune Checkpoint Inhibitors.
Asher N; Marom EM; Ben-Betzalel G; Baruch EN; Steinberg-Silman Y; Schachter J; Shapira-Frommer R; Markel G
Oncologist; 2019 May; 24(5):640-647. PubMed ID: 30777894
[TBL] [Abstract][Full Text] [Related]
18. Toripalimab combined with anlotinib for recurrent extensive‑stage small‑cell lung cancer: A case report.
Wu Y; Chen Y; Yang Z
Exp Ther Med; 2023 Jul; 26(1):313. PubMed ID: 37273750
[TBL] [Abstract][Full Text] [Related]
19. A case report of advanced thymoma re-treated with PD-1 inhibitor after initial immune-related pneumonitis.
Zhang Y; Li W; Hu X; Zhang J
Ann Palliat Med; 2021 Sep; 10(9):10083-10090. PubMed ID: 34551569
[TBL] [Abstract][Full Text] [Related]
20. Rapid temporal improvement of pembrolizumab-induced pneumonitis using the anti-TNF-α antibody infliximab.
Sawai Y; Katsuya Y; Shinozaki-Ushiku A; Iwasaki A; Fukayama M; Watanabe K; Nagase T
Drug Discov Ther; 2019 Jul; 13(3):164-167. PubMed ID: 31257354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
